Hematologic Malignancy
Acute Biphenotypic Leukemia
CI-CAN-00007129Explore in graph →
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00007129Explore in graph →
Variants & evidence
2 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|
| KMT2A Fusion1 | |||||||
| EPZ004777 | Predictive | D | Supports Sensitivity Response | 4 | submitted | EID7582KMT2A (MLL) gene encodes a transcriptional co-activator harboring a SET domain with H3K4 histone methyl transferase activity which mediates chromatin modifications associated with epigenetic transcrip… (full text at CIViC) PMID 21741596 · Daigle et al., 2011 · Open in CIViC | civic |
| ZNF384 Fusion1 | |||||||
| (diagnostic) | Diagnostic | C | Supports Positive | 1 | submitted | EID9708A case report of a 74 year old female who was diagnosed with MPAL, B/myeloid with bone marrow blasts were positive for myeloperoxidase, CD19, and CD22. Chromosome analysis showed 46,XX,+1,der(1;18)(q1… (full text at CIViC) PMID 27607436 · Yamamoto et al., 2016 · Open in CIViC | civic |
Data updated 21 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.